钴60远距离治疗膀胱癌 - Suppr | 超能文献

Cobalt 60 teletherapy of carcinoma of the bladder.

作者信息

Edsmyr F, Jacobsson F, Dahl O, Walstam R

出版信息

Acta Radiol Ther Phys Biol. 1967 Apr;6(2):81-99. doi: 10.3109/02841856709138567.

DOI:10.3109/02841856709138567

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Cobalt 60 teletherapy of carcinoma of the bladder.钴60远距离治疗膀胱癌

Acta Radiol Ther Phys Biol. 1967 Apr;6(2):81-99. doi: 10.3109/02841856709138567.

2

[Cobalt teletherapy in 124 cases of bladder neoplasms].[124例膀胱肿瘤的钴远距离治疗]

Ateneo Parmense 1. 1971 Jul-Aug;42(4):401-24.

3

[Clinico-statistical survey on radiocobalt teletherapy of 139 bladder neoplasms].[139例膀胱肿瘤放射性钴远距离治疗的临床统计学调查]

Quad Radiol. 1968 Sep-Oct;33(5):467-83.

4

[Radiotherapy of tumors of the urogenital system].[泌尿生殖系统肿瘤的放射治疗]

Radiobiol Radiother (Berl). 1969;10(4):475-88.

5

TELECOBALT TREATMENT OF CARCINOMA OF THE BLADDER.膀胱癌的远距钴治疗

Clin Radiol. 1965 Apr;16:165-72. doi: 10.1016/s0009-9260(65)80016-2.

6

Radiotherapy for transitional-cell carcinoma of the urinary bladder with cobalt 60.用钴60对膀胱移行细胞癌进行放射治疗。

Radiology. 1966 Dec;87(6):1053-7 passim. doi: 10.1148/87.6.1053.

7

Treatment of infiltrating bladder cancer by cobalt 60 radiation: recurrence of tumor in bladder after initial disappearance.钴60放疗治疗浸润性膀胱癌：肿瘤最初消失后膀胱内肿瘤复发。

J Urol. 1969 Jun;101(6):859-62. doi: 10.1016/s0022-5347(17)62442-x.

8

[Discussion: the results of treatment of bladder cancer].[讨论：膀胱癌的治疗结果]

J Urol Nephrol (Paris). 1966 Dec;72(12):Suppl:229-348.

9

[Therapy and prognosis of bladder carcinoma. Therapy and the course of disease in a group of 90 patients in the years 1956-1963].[膀胱癌的治疗与预后。1956年至1963年间90例患者的治疗及病程]

Z Urol Nephrol. 1970 Jan;63(1):27-34.

10

[Therapeutic indications in bladder cancer].[膀胱癌的治疗指征]

Acta Urol Belg. 1971 Jan;39(1):5-7.

引用本文的文献

1

The role of exfoliative cytology in the management of bladder carcinoma.脱落细胞学在膀胱癌管理中的作用。

Urol Res. 1978;6(4):197-200. doi: 10.1007/BF00262617.

2

Chemotherapy in the management of invasive bladder cancer. A review.

Cancer Chemother Pharmacol. 1979;3(2):87-96. doi: 10.1007/BF00254978.